155 related articles for article (PubMed ID: 37211917)
1. LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1.
Liu H; Wang X; Guo Z; Sun G; Lv Q; Qin C; Yuan L; Wang Y; Du M; Wang M; Zhang Z; Chu H
Cancer Med; 2023 Jul; 12(13):14440-14451. PubMed ID: 37211917
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing related genetic variants contribute to bladder cancer risk.
Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z
Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354
[TBL] [Abstract][Full Text] [Related]
3. lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility.
Xu C; Liu M; Jia D; Tao T; Hao D
Genet Test Mol Biomarkers; 2021 Jan; 25(1):31-41. PubMed ID: 33372851
[No Abstract] [Full Text] [Related]
4. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
Li Z; Niu Y
Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in splicing factor genes and susceptibility to bladder cancer.
Wang X; Guo Z; Zhu H; Xin J; Yuan L; Qin C; Wang M; Zhang Z; Wang Y; Chu H
Gene; 2022 Jan; 809():146022. PubMed ID: 34673209
[TBL] [Abstract][Full Text] [Related]
6. The association of rs710886 in lncRNA PCAT1 with bladder cancer risk in a Chinese population.
Lin Y; Ge Y; Wang Y; Ma G; Wang X; Liu H; Wang M; Zhang Z; Chu H
Gene; 2017 Sep; 627():226-232. PubMed ID: 28627442
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
[TBL] [Abstract][Full Text] [Related]
8. A Single Nucleotide Polymorphism in GAS5 lncRNA is Associated with Risk of Bladder Cancer in Iranian Population.
Rakhshan A; Esmaeili MH; Kahaei MS; Taheri M; Omrani MD; Noroozi R; Ghafouri-Fard S
Pathol Oncol Res; 2020 Apr; 26(2):1251-1254. PubMed ID: 31250374
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population.
Hua Q; Lv X; Gu X; Chen Y; Chu H; Du M; Gong W; Wang M; Zhang Z
Mutagenesis; 2016 Sep; 31(5):531-8. PubMed ID: 27091055
[TBL] [Abstract][Full Text] [Related]
10. Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.
Zheng R; Du M; Ge Y; Gao F; Xin J; Lv Q; Qin C; Zhu Y; Gu C; Wang M; Zhu Q; Guo Z; Ben S; Chu H; Ye D; Zhang Z; Wang M
Oncogene; 2021 Apr; 40(13):2382-2394. PubMed ID: 33658628
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
12. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
[TBL] [Abstract][Full Text] [Related]
14. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of
He S; Cao R; Mao Y; Li N; Wang Y; Ma H; Tian K
J Gynecol Oncol; 2023 May; 34(3):e40. PubMed ID: 36731897
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.
Lee EK; Ye Y; Kamat AM; Wu X
Cancer; 2013 May; 119(9):1643-51. PubMed ID: 23529717
[TBL] [Abstract][Full Text] [Related]
17. Tagging SNPs in the HOTAIR gene are associated with bladder cancer risk in a Chinese population.
Wang X; Wang W; Zhang Q; Gu D; Zhang K; Ge Y; Chu H; Du M; Xu B; Wang M; Lv X; Zhang Z; Yuan L; Gong W
Gene; 2018 Jul; 664():22-26. PubMed ID: 29673865
[TBL] [Abstract][Full Text] [Related]
18. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
19. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
[TBL] [Abstract][Full Text] [Related]
20. A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding.
Gong J; Tian J; Lou J; Ke J; Li L; Li J; Yang Y; Gong Y; Zhu Y; Zhang Y; Zhong R; Chang J; Miao X
Carcinogenesis; 2016 May; 37(5):443-51. PubMed ID: 26905585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
